Growth hormone (HGH) is a hormone of the human body that contributes to the repair and metabolism of cells. If you move into gyms, then you have heard of it. Why? Let's start from the beginning.

Ascendis Pharma A/S (NASDAQ:ASND) released topline results from Phase 3 foresiGHt trial to compare the efficacy and safety of TransCon hGH (lonapegsomatropin) with placebo and daily hGH (human growth ...

Dublin, Oct. 04, 2023 (GLOBE NEWSWIRE) -- The "Somatropin Market, By Dosage Form, By Application, By Distribution Channel, and By Region (North America, Latin America, Europe, Asia Pacific, Middle ...

– On primary efficacy and key secondary endpoints, TransCon hGH demonstrated statistically significant reduction from baseline in trunk fat and increase in total body lean mass at Week 38 compared to ...

COPENHAGEN, Denmark, July 28, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food & Drug Administration (FDA) has approved SKYTROFA® (lonapegsomatropin-tcgd; ...

NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) has approved NGENLA (somatrogon-ghla), a ...

Somatropin, also known as human growth hormone (HGH), is a synthetic version of the naturally occurring hormone produced by the pituitary gland. It plays a crucial role in various physiological ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved long-acting once-weekly somatrogon for children with growth hormone deficiency. Somatrogon was ...

Ascendis Pharma announced positive results from the Week 26 analysis of its Phase 2 trial, New InsiGHTS, which studied once-weekly TransCon hGH for prepubertal children with Turner syndrome. The trial ...

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Somapacitan was noninferior to somatropin in improving yearly growth rate in children born SGA, or with NS or ISS. Topline data were announced from a phase 3 trial evaluating somapacitan in ...

March 5, 2010 — The US Food and Drug Administration (FDA) has approved a prefilled somatropin (rDNA origin) injection pen (Norditropin FlexPro, Novo Nordisk, Inc) for the treatment of growth hormone ...